News
February 2007
Sanofi Still To Receive Approval
19 February 2007 :Acomplia, the most important
drug of Sanofi Aventis gets delayed again by the FDA for the third time...Read
More...
No Viagra: Disappointed Customers
16 February 2007 :A valentine’s night
is a night to remember and Jim Dante wanted to give just that to his wife.
As he heard that Boots has started selling viagra
over the counter...Read
More...
French
Health Advisory Body Recommends Acomplia
07 February 2007 :Scope of reimbursement
stated for Acomplia, by the
transparency committee at the health authorities who have published their
recommendation...Read
More...
Menstruation To Be Influenced With Weight
05 February 2007 :The term menstruation
is also known as menarche, and the age at which girls start their menstruation,
may be early if they were small babies, but heavy as children, as was
stated according to an Australian study...Read
More...
Sex Caused Emotional Harm Among Teens
05 February 2007 :According to a study teenagers
suffered from emotional consequences after having sex, even if it was
oral sex...Read More...
Paranoia
because of Viagra
02 February 2007 :The lawsuit has alleged
that the ads of Pfizer’s Viagra are misleading and false. AHF (AIDS
Healthcare Foundation) also launched an ad campaign that makes similar
claims. AHF accused the drug company Pfizer of advertising Viagra
to men who did not suffer from erectile dysfunction...Read
More...
Sex
Issues May Signal Other Health Risks
02 February 2007 :Doctors shouldn't shy
away from asking patients about their sex lives, a new research paper
advises...
Read More...
Benefit
with an Apt E.D. drug
01 February 2007 :Endothelial dysfunction
is when the inner lining of the blood vessels don't function properly,
which means blood doesn't flow as it should. It can be a complication
of many issues including heart disease, diabetes, high blood pressure,
prostate surgery or alcoholism...Read
More...
Sanofi's
Acomplia Looses its Ranking
01 February 2007 :It was anticipated that
Acomplia would get the approval of FDA, but the decision was delayed till
April. With this delay in the emergence of Acomplia, other drug makers
got time to manufacture drugs with the same use and effectiveness. An
expected amount of $ 7 billion was expected out of Acomplia...
Read More...
|
